News
Approval was based on results from the Phase III inMIND trial, which demonstrated a statistically significant and clinically ...
Pfizer’s 7%+ yield is tempting, but rising political, regulatory, and business risks threaten its stability and growth ...
Robert F. Kennedy Jr. (RFK Jr.) has only been Secretary of the Department of Health and Human Services (HHS) since ...
A new Lyme disease vaccine, VLA15, is currently being tested and the manufacturers could ask the FDA for authorization as ...
Dr Martin J Tobin discusses health disparities related to pulse oximeter accuracy and the need for improvement to make health care equitable.
The Food and Drug Administration (FDA) announced a new crackdown Wednesday on the flow of American DNA to labs in ...
19h
Zacks Investment Research on MSNPfizer vs BMY: Which Oncology Drugmaker Is a Better Choice for Now?Pharma/biotech giants Pfizer PFE and Bristol Myers BMY boast of a dominant position in the lucrative oncology space. Oncology ...
The approach could enable 30-minute testing for a heart condition that is newly treatable following recent drug approvals.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results